Does CASPOFUNGIN Cause Product use in unapproved indication? 257 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 257 reports of Product use in unapproved indication have been filed in association with CASPOFUNGIN (CASPOFUNGIN ACETATE). This represents 6.7% of all adverse event reports for CASPOFUNGIN.
257
Reports of Product use in unapproved indication with CASPOFUNGIN
6.7%
of all CASPOFUNGIN reports
55
Deaths
52
Hospitalizations
How Dangerous Is Product use in unapproved indication From CASPOFUNGIN?
Of the 257 reports, 55 (21.4%) resulted in death, 52 (20.2%) required hospitalization, and 4 (1.6%) were considered life-threatening.
Is Product use in unapproved indication Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for CASPOFUNGIN. However, 257 reports have been filed with the FAERS database.
What Other Side Effects Does CASPOFUNGIN Cause?
Drug ineffective (1,060)
Off label use (325)
Multiple organ dysfunction syndrome (215)
Drug resistance (194)
Septic shock (165)
Aspergillus infection (154)
Drug reaction with eosinophilia and systemic symptoms (136)
Systemic mycosis (129)
Pyrexia (128)
Death (120)
What Other Drugs Cause Product use in unapproved indication?
DUPILUMAB (33,452)
DICLOFENAC (12,197)
METHOTREXATE (8,930)
PREDNISONE (7,625)
RITUXIMAB (7,519)
MYCOPHENOLATE MOFETIL (5,910)
ACETAMINOPHEN (5,819)
CYCLOPHOSPHAMIDE (5,750)
RISPERIDONE (5,551)
TACROLIMUS (5,057)
Which CASPOFUNGIN Alternatives Have Lower Product use in unapproved indication Risk?
CASPOFUNGIN vs CATEQUENTINIB
CASPOFUNGIN vs CC-4047
CASPOFUNGIN vs CEDAZURIDINE\DECITABINE
CASPOFUNGIN vs CEDIRANIB
CASPOFUNGIN vs CEFACLOR